HOME >> BIOLOGY >> NEWS
Researchers to compare prenatal treatments for serious twin complication

Researchers at The Childrens Hospital of Philadelphia are beginning a study to compare two treatments for a serious condition that may occur in pregnant women carrying twins. In twin-twin transfusion syndrome (TTTS), abnormal circulation between the twins and the placenta they share may cause one twin to be much smaller than the other, and surrounded by much less amniotic fluid. The imbalance in circulation may kill one or both fetuses, or damage the health of twins who survive.

Physicians usually diagnose TTTS using prenatal ultrasound, augmented by other tests such as fetal magnetic resonance imaging and amniocentesis. Although TTTS occurs in only 200 to 1800 pregnancies annually in the U.S., the condition has a disproportionately high impact. In approximately 17 percent of cases in which a twin dies before, during or shortly after birth, the cause is TTTS. Estimates of the frequency of TTTS vary widely because of differing criteria for diagnosing the syndrome.

Timothy M. Crombleholme, M.D., a pediatric and fetal surgeon at the Center for Fetal Diagnosis and Treatment at Childrens Hospital, is the principal investigator of the national, multicenter clinical trial, which is comparing two treatments for TTTS. The current standard treatment is amnioreduction, in which excess amniotic fluid surrounding one fetus is drained through a needle inserted into the mothers abdomen. Another treatment, laser photocoagulation, uses heat from a laser, inserted through a flexible tube, or fetoscope, to seal off the blood vessels connecting the two fetuses. The goal of the laser treatment is to separate the communicating circulation between the twins which causes the syndrome.

Without prenatal treatment for TTTS, both twins usually die. Even with treatment, survival of both twins is not guaranteed, and survivors are nearly always born prematurely, sometimes with health complications, including brain injury and heart conditions related to the abnormal pre
'"/>

Contact: John Ascenzi
Ascenzi@email.chop.edu
215-590-7332
Children's Hospital of Philadelphia
22-Apr-2002


Page: 1 2

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... August 24, 2020 , ... Elgia Therapeutics , ... fibrotic diseases, today announced that Dr. Stacie Canan has joined the company as ... previously served as Executive Director of Global Health at Bristol Myers Squibb (formerly ...
(Date:8/21/2020)... ... August 18, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage ... Food and Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) ... severe COVID-19. Approval of this IND allows Sentien to initiate a Phase 1/2 ...
(Date:8/12/2020)... ... , ... Mosio recently announced its newly updated text message-based ... all sizes. With a focus on tracking symptoms and monitoring outbreaks as well ... helps public health departments automate communications and provide more personalized care and resources ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... 29, 2020 , ... G-CON Manufacturing, the leader in off-site ... FOR LIFE.” The adoption of this taglines comes at a time of tremendous ... to provide patients with urgently needed vaccines and other lifesaving pharmaceutical treatments. G-CON’s ...
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted as ... cover the history of eSource, the reasons it did not take off as quickly ... site source, the industry is moving towards capturing data electronically for clinical trials and ...
(Date:7/18/2020)... ... , ... After research model surgery and catheter implantation, the long journey of ... beginning of a successful study, while protecting and accessing the catheter or device post-surgery ... Surgery from Envigo in a live webinar on Wednesday, August ...
(Date:7/10/2020)... LORTON, Va. (PRWEB) , ... July 08, 2020 ... ... laboratory testing services and products, announces a significant expansion of laboratory operations through ... robust collection for agencies implementing testing programs. , Bode-CARES provides ...
Breaking Biology Technology:
Cached News: